ARCHIVES

IOM To Form Committee To Investigate Duke Genomics Research

This article is from The Cancer Letter archive.

Vol. 36 No. 35 | October 1, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

NCI Advisory Board Approves Three Concepts

December 19, 2014

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

October 20, 1995

Funding opportunities listed.

October 8, 2004